These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3383549)

  • 41. [Effects of ampicillin and cefazolin combined with mecillinam (author's transl)].
    Stille W; Bischof-Léger E; Helm EB
    Arzneimittelforschung; 1978; 28(10):1661-4. PubMed ID: 226099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergic post-antibiotic effect of mecillinam, in combination with other beta-lactam antibiotics in relation to morphology and initial killing.
    Hanberger H; Nilsson LE; Svensson E; Maller R
    J Antimicrob Chemother; 1991 Oct; 28(4):523-32. PubMed ID: 1761447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.
    Zhanel GG; Karlowsky JA; Schwartz B; Jensen SB; Hoban DJ
    Chemotherapy; 1998; 44(6):391-6. PubMed ID: 9755298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro combination-effect of temocillin with ticarcillin and aminoglycosides on gram-negative and gram-positive bacteria.
    Just HM; Becker C; Gieringer J; Wenz A; Bassler M; Daschner F
    Drugs; 1985; 29 Suppl 5():74-7. PubMed ID: 4029031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin.
    Watanakunakorn C; Glotzbecker C
    J Antibiot (Tokyo); 1979 Oct; 32(10):1019-24. PubMed ID: 528361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quaternary heterocyclylamino beta-lactams. IV. Comparison of the in vivo antibacterial activities of L-640,876, mecillinam, cefoxitin and cefotaxime.
    Celozzi E; Pelak BA; Stapley EO; Gadebusch HH
    J Antibiot (Tokyo); 1983 Jan; 36(1):64-9. PubMed ID: 6088459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro evaluation of new penicillins and cephalosporins upon P. aeruginosa and their interaction with mecillinam.
    Perea EJ; Palomares JC; García-Iglesias MC
    Chemotherapy; 1980; 26(4):282-8. PubMed ID: 6248300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasmid-mediated beta-lactamases among aminoglycoside resistant gram-negative bacilli.
    Huovinen S; Klossner ML; Katila ML; Huovinen P
    Scand J Infect Dis; 1989; 21(3):303-9. PubMed ID: 2667097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Beta-lactam-resistance patterns of some gram-negative rods].
    Janicka G; Kania I; Białek M; Kruszyńska E; Wiktorowicz-Belzyt E; Mikucka A; Czajkowski H
    Pol Merkur Lekarski; 1999 Jan; 6(31):12-4. PubMed ID: 10344146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bactericidal effect of piperacillin alone and combined].
    Drugeon HB; Caillon J; Moinard D; Juvin ME; Pirault JL
    Presse Med; 1986 Dec; 15(46):2297-302. PubMed ID: 2949271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents.
    Glupczynski Y; Hansen W; Freney J; Yourassowsky E
    Antimicrob Agents Chemother; 1988 Feb; 32(2):276-8. PubMed ID: 3163242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Penicillin-binding proteins and role of amdinocillin in causing bacterial cell death.
    Neu HC
    Am J Med; 1983 Aug; 75(2A):9-20. PubMed ID: 6311012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA; Hare R; Papa E; Adam C; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
    Betriu C; Sánchez A; Gómez M; Palau ML; Picazo JJ
    J Antimicrob Chemother; 1999 Jan; 43(1):133-6. PubMed ID: 10381111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam.
    Appelbaum PC; Spangler SK; Jacobs MR
    J Antimicrob Chemother; 1993 Aug; 32(2):223-31. PubMed ID: 8226424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study of the enhancement of beta-lactam activity by amdinocillin in a model of the human urinary bladder.
    Anderson JD; Eftekhar F
    Am J Med; 1983 Aug; 75(2A):42-7. PubMed ID: 6311004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients.
    Stutman HR; Welch DF; Scribner RK; Marks MI
    Antimicrob Agents Chemother; 1984 Feb; 25(2):212-5. PubMed ID: 6538772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-vitro activity of the combinations of ampicillin with mecillinam or with beta-lactamase inhibitors against strains resistant to ampicillin.
    Verbist L
    J Antimicrob Chemother; 1985 Dec; 16(6):719-25. PubMed ID: 3879248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.